MEYER ANDREW HOLLMAN (Chief Business Officer) sold 3.8% of their position (3.33K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $109.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/3/2025ACC: 0001864159-25-000006
Officer· Chief Business Officer
Since Jun 2021
-3.33K
Net shares
Net seller
$109.9K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
3.33K acquired · 6.67K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.33K
Price / share
$10.59
Trade value
$35.30K
% of position
3.9%
12/1/2025
84.97K→88.31K
Common Stock
Direct
Shares
−2.70K
Price / share
$32.85
Trade value
$88.71K
% of position
3.1%
12/1/2025
88.31K→85.61K
Common Stock
Direct
Shares
−633.00
Price / share
$33.52
Trade value
$21.22K
% of position
0.7%
12/1/2025
85.61K→84.97K
Total
Net shares
+0.00
Net value
-$74.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | M · Option Exercise | +3.33K | $10.59 | $35.30K | 3.9% | 84.97K | 88.31K |
| Common Stock Direct | 12/1/2025 | S · Sale | −2.70K | $32.85 | $88.71K | 3.1% | 88.31K | 85.61K |
| Common Stock Direct | 12/1/2025 | S · Sale | −633.00 | $33.52 | $21.22K | 0.7% | 85.61K | 84.97K |
| Total | +0.00 | -$74.63K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.33K shares
Shares
−3.33K
Strike price
10.59
Held after
114.77K
Exercisable
—
12/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.33K shares | 12/1/2025 | M · Option Exercise | −3.33K | 10.59 | — | 114.77K |